| Trade name of the product: |
| Sandostatina |
| Pharmaceutical active ingredients: |
| Octreotide Acetate |
| Available forms, composition and doses of Sandostatina: |
| Injectable; Injection; Octreotide Acetate 0.2 mg / ml |
| Medical categories: |
| Human:Trophic hormones and related synthetic drugs |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| H01CB02 - Octreotide |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Novartis |
| Related documents and information about Sandostatina: |
| Sandostatin prescribing information (PDF)Sandostatin LAR prescribing information (PDF) |